A Bit About Us
People who are currently receiving buprenorphine or methadone medication are needed for a UVM research study examining a cognitive-behavioral treatment for people who have experienced traumatic events!
Trauma exposure is common among people with opioid use disorder (OUD). When PTSD and OUD occur together, people often experience more severe mental health symptoms and worse opioid agonist treatment (OAT) outcomes than when either disorder occurs alone. Fortunately, prolonged exposure therapy (PET) is an efficacious manualized cognitive-behavioral treatment for reducing trauma and posttraumatic stress disorder symptoms.
This new UVM study will produce important new scientific and clinical information related to how OAT and PET promote reductions in PTSD symptomatology.
Furthermore, this project holds significant potential for improving functioning, quality of life, and psychiatric distress for people with PTSD and OUD, as well as public health more generally.
Click "Learn More" to complete an online pre-screening or "Our Study" for more information.